| 1 |
32622356 | Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature. | 2020 Jul 4 |
1 |
| 2 |
29530932 | Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance. | 2018 Jul 1 |
2 |
| 3 |
30296375 | Erlotinib-Guided Self-Assembled Trifunctional Click Nanotheranostics for Distinguishing Druggable Mutations and Synergistic Therapy of Nonsmall Cell Lung Cancer. | 2018 Nov 5 |
1 |
| 4 |
27165055 | Mechanisms of skin aging induced by EGFR inhibitors. | 2016 Oct |
1 |
| 5 |
25714397 | Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation. | 2015 |
1 |
| 6 |
25164437 | pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104. | 2014 Aug 28 |
1 |
| 7 |
23769318 | Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer. | 2013 Sep |
1 |
| 8 |
23856246 | The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. | 2013 Jul 15 |
1 |
| 9 |
21109480 | p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma. | 2011 Jan |
1 |
| 10 |
15035290 | Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines. | 2004 Mar |
1 |